ThredUp (TDUP) Q1 2025 Earnings Call May 05, 2025 04:30 PM ET Speaker0 Good afternoon, ladies and gentlemen, and welcome to the ThredUP First Quarter twenty twenty five Earnings Conference Call. At this time, all lines are in listen only mode. Following the presentation, we will conduct a question and answer session. This call is being recorded on Monday, May fifth of twenty twenty five. I would now like to turn the conference over to Lauren Fresh. Please go ahead. Speaker1 Good afternoon, everyone, and tha ...

Artivion (AORT) Q1 2025 Earnings Call May 05, 2025 04:30 PM ET Company Participants Laine Morgan - Associate Vice PresidentPatrick Mackin - Chairman , President & CEOLance Berry - Executive VP & CFOJohn McAulay - AVPSuraj Kalia - Managing DirectorDaniel Stauder - Director - Equity ResearchJeffrey Cohen - MD - Equity Research Conference Call Participants Frank Takkinen - Senior Research AnalystMichael Matson - Senior Analyst Operator Greetings. Welcome to our Ativian's First Quarter twenty twenty five Financ ...

Financial Data and Key Metrics Changes - The company reported first quarter product sales of $545 million for INGREZZA, with a reaffirmed sales guidance range for 2025 of $2.5 billion to $2.6 billion, reflecting expected acceleration in new patient additions despite gross to net impacts from contracting activities [8][9][10] - The company has approximately $1.8 billion in cash, supporting its commercial and clinical development strategies for continued growth [11] Business Line Data and Key Metrics Changes - INGREZZA achieved record new patient starts in the first quarter, indicating strong demand and unmet medical needs [9][12] - KRONESITY generated $15 million in net revenue during its first full quarter of launch, with 70% of dispensations receiving reimbursement [10][16] Market Data and Key Metrics Changes - The formulary coverage for INGREZZA in Medicare Part D expanded from less than half to approximately two-thirds, improving patient access [14] - The company noted that 70% of the dispensers for KRONESITY were reimbursed, although most reimbursement was through the exceptions process rather than formal reviews [40] Company Strategy and Development Direction - The company aims to evolve from a single blockbuster to a multiple blockbuster neuroscience company, focusing on both near and long-term revenue growth [5][7] - The R&D portfolio is advancing, with ongoing Phase III studies for osevampatore and MBI-568, and plans to expand the muscarinic portfolio into new Phase II studies later this year [6][20] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the momentum from record new patient starts and the potential for growth in the second quarter and beyond, despite challenges in the reauthorization process and market dynamics [31][32] - The management team highlighted the importance of continued investment in sales force expansion and marketing initiatives to strengthen INGREZZA's market position [15][16] Other Important Information - The company is transitioning leadership, with Dr. Eiry Roberts moving to a strategic advisory role and Dr. Sanjay Keswani set to become the new Chief Medical Officer [6][25] - The company is focused on increasing awareness and reducing stigma around tardive dyskinesia, collaborating with various organizations to improve patient access to treatment [12][14] Q&A Session Summary Question: Insights on INGREZZA's performance and future growth - Management acknowledged challenges in Q1 but noted record new patient starts, indicating strong momentum going into Q2 and the rest of the year [31][32] Question: Expectations for KRONESITY's adoption and reimbursement dynamics - Management indicated that while initial adoption exceeded expectations, it is too early to define long-term trends, and they will continue to monitor reimbursement patterns [35][40] Question: Share dynamics between INGREZZA and competitors - Management stated that INGREZZA continues to hold a majority share in the tardive dyskinesia market, with ongoing efforts to differentiate from competitors [44] Question: Insights on patient demographics for KRONESITY - Management noted an early trend towards greater uptake in pediatric and adolescent patients compared to adults, aligning with pre-launch expectations [46][69] Question: Contracting strategies and pricing trends for INGREZZA - Management emphasized a focus on maximizing patient access through prudent contracting, with no immediate changes anticipated but ongoing monitoring of the environment [59][82]

Financial Data and Key Metrics Changes - First quarter revenues were $244.5 million, up 5% sequentially from Q4 and 21% year-over-year [5][20] - Gross margin for Q1 was 12.4%, an increase of 40 basis points from Q4 but below the forecast of 14.5% [20] - Operating income for Q1 was $6.6 million, with a net interest expense of $1.6 million and a non-GAAP net income tax expense of $600,000 [20] - Free cash flow was $500,000 after generating $19 million in cash flow from operations and deducting $18.5 million in capital expenditures [21] Business Line Data and Key Metrics Changes - The company acknowledged challenges in transitioning from externally supplied products to internally manufactured products, impacting gross margins [6][20] - A new contract in the commercial space market led to higher costs and revenue push-outs due to redesign requirements [9] - The decision to exit the refurbishment business in Scotland had a slight negative impact on both revenue and gross margin [9] Market Data and Key Metrics Changes - The overall customer demand environment has remained consistent, with expectations for modest growth in wafer fab equipment (WFE) for 2025 [5] - The company expects revenue growth to outperform overall WFE growth in 2025 [5] - Specific markets such as silicon carbide applications have weakened, affecting OEM customers differently [14] Company Strategy and Development Direction - The company aims to increase the use of proprietary, internally sourced components to drive gross margin expansion [10] - By the end of 2025, the company expects to have all four major customers qualified on all three major product families: valves, fittings, and substrates [12] - Planned capital expenditures for 2025 are expected to be around 4% of revenue, higher than the historical average of 2% [22] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the demand for products and qualifications, despite challenges in aligning supply with demand [60] - The company is working to mitigate the impact of tariffs on gross margins and is optimistic about collaboration with customers [42] - Visibility for the second half of the year is less certain, but management believes the business will be relatively evenly weighted between the first and second halves of 2025 [15] Other Important Information - The company is facing complexities due to recent tariff announcements, particularly affecting steel and aluminum imports [12][13] - The exit from the refurbishment business in Scotland was primarily due to declining demand, resulting in a loss of approximately $10 million in annual revenue [96] Q&A Session Summary Question: Change in revenue outlook for the year - Management noted that the lithography business is softer, primarily due to the exit from Scotland, while NAND investment continues [27][29] Question: Gross margins and tariff impacts - Management indicated that they executed about 75% to 80% of their internal sourcing goals, with ongoing improvements expected [32] Question: Customer behavior regarding tariffs - Management stated that customers are collaborating to address tariff impacts, with some costs being passed through [42] Question: Confidence in second half growth - Management expressed confidence in continued strength in DRAM and NAND upgrades, with expectations for growth in the second half [46] Question: Disconnect with largest customer guidance - Management believes there are natural offsets in the market, and they do not see significant disconnects from customer forecasts [54] Question: Impact of exiting Scotland operations - The exit from Scotland was primarily responsible for severance costs, with the majority of the impact coming from that decision [65] Question: Monitoring steps for gross margins - Management acknowledged the need for better forecasting and alignment between supply and demand, with plans for deeper organizational oversight [72] Question: Long-term view on internal sourcing - Management maintains a positive long-term view on incremental margins from internal sourcing, with ongoing improvements expected [82]

Neurocrine Biosciences (NBIX) Q1 2025 Earnings Call May 05, 2025 04:30 PM ET Company Participants Todd Tushla - VP, IRKyle Gano - CEOMatt Abernethy - Chief Financial OfficerEric Benevich - Chief Commercial OfficerEiry Roberts - Chief Medical OfficerPaul Matteis - Managing Director, Head of Therapeutics ResearchPhoebe Tan - Senior Biotechnology Equity Research AssociateTazeen Ahmad - MD - US Equity ResearchPhilip Nadeau - MD, Health Care – BiotechnologyBrian Abrahams - MD & Global Sector Head - Health Care R ...

Ekso Bionics (EKSO) Q1 2025 Earnings Call May 05, 2025 04:30 PM ET Speaker0 Greetings, and welcome to the Ekso Bionics First Quarter twenty twenty five Financial Results Conference Call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Stephen Comer of Investor Relations. Thank you. You may begin. Speaker1 Thank you, operator, and good af ...

EverQuote (EVER) Q1 2025 Earnings Call May 05, 2025 04:30 PM ET Speaker0 Good afternoon, ladies and gentlemen, and thank you for standing by. My name is Calvin, and I will be your conference operator today. At this time, I would like to welcome everyone to the EverQuote First Quarter twenty twenty five Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer Thank you. I would now like to turn the call over to Brinley ...

Vertex Pharmaceuticals (VRTX) Q1 2025 Earnings Call May 05, 2025 04:30 PM ET Speaker0 Good day, and welcome to the Vertex Pharmaceuticals First Quarter twenty twenty five Earnings Call. All participants will be in a listen only mode. After today's presentation, there will be an opportunity to ask questions. Please note this event is being recorded. I would now like to turn the conference over to Ms. Susie Lisa. Please go ahead, ma'am. Speaker1 Good evening, all. My name is Susie Lisa, and as the Senior Vice ...

Financial Data and Key Metrics Changes - Denny's reported Q1 domestic system-wide same restaurant sales decreased by 3% compared to the previous year, with company same restaurant sales down by 0.9% and franchise same restaurant sales down by 3.2% [16][17] - Total operating revenue for the quarter was $111.6 million, up from $110 million in the prior year quarter, driven by additional Kiki's units and higher local advertising contributions [23] - Adjusted net income per share was $0.08, with an adjusted EBITDA of $16.8 million [30] Business Line Data and Key Metrics Changes - Denny's same restaurant sales decreased by 3% in Q1, but April saw same restaurant sales approximately flat due to the successful Buy One Slam, Get One for $1 promotion [6][7] - Kiki's Breakfast Cafe achieved a same restaurant sales increase of 3.9% in Q1, significantly outperforming the BBI Family Dining Index in Florida [12][20] - Off-premise sales contributed positively, improving same restaurant sales by 1% and representing 22% of total sales [18][11] Market Data and Key Metrics Changes - California and Florida were the strongest markets for Denny's, with California outperforming the BBI Family Dining Sales Index for the fifth consecutive quarter [16] - Consumer sentiment remains negative, particularly among lower-income households, impacting overall sales performance [6][17] Company Strategy and Development Direction - The company is focusing on value-driven initiatives and promotional offers to attract customers in a challenging economic environment [5][6] - Denny's is committed to expanding Kiki's Breakfast Cafe, with plans for 12 to 20 new openings this year, and has opened six new cafes year-to-date [22][12] - The company is also enhancing its digital presence and off-premise strategies to capture a broader audience [10][11] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism about the second quarter, noting improvements in consumer sentiment and sales trends [31][50] - The company anticipates being in the lower half of its same restaurant sales guidance range for the year, projecting a range of negative 2% to positive 1% [31][32] - Management highlighted the importance of ongoing promotional strategies and value offerings to maintain customer engagement [39][41] Other Important Information - The company completed six remodels during the quarter, with over 50% of its company fleet remodeled under the new image [19] - Commodity costs, particularly for eggs, have significantly impacted margins, with expectations for prices to moderate in the coming months [25][27] Q&A Session Summary Question: How is the strategy of introducing new value offers shaping the outlook for the rest of the year? - Management indicated that the promotional value strategy is essential in the current environment, and they will continue to refine it while monitoring consumer needs [39][40] Question: Are there signs of improvement in consumer sentiment across different cohorts? - Management noted that all income cohorts showed improvement in April, particularly those earning above $60,000 [52] Question: What is the franchisee appetite for promotions like the BOGO offer? - Franchisees have responded positively to the BOGO promotion, which has driven traffic and improved overall sales [56][58] Question: What is the outlook for menu pricing and its impact on same-store sales? - The company expects approximately 4% to 4.5% of pricing to be implemented in 2025, with a cautious approach to future pricing adjustments based on market conditions [63][64] Question: How is the company managing the impact of new cafe openings on margins? - Management acknowledged that new cafes typically experience inefficiencies initially, but they are working to optimize operations over time [96][98] Question: What is the expected impact of egg prices on margins moving forward? - Management indicated that the worst impact from egg prices was seen in Q1, with expectations for moderation in the following quarters [100]

Financial Data and Key Metrics Changes - The company reported a total revenue growth of 18% and adjusted EBITDA growth of 32% for the first quarter [13][17] - The projects business revenue grew by 23%, while energy asset revenue increased by 31% [14][17] - The net income attributable to common shareholders was a loss of $5,500,000 or $0.10 per share [16] Business Line Data and Key Metrics Changes - The total project backlog increased by 22% to $4,900,000,000, with a contracted project backlog growing by 80% to $2,600,000,000 [17] - The energy asset operating base now stands at 742 megawatts, reflecting significant growth compared to the previous year [14] Market Data and Key Metrics Changes - The company experienced strong performance in Europe and Canada, contributing to the overall revenue growth [14] - Approximately 30% of the current total project backlog is attributed to federal government contracts, with military-related customers accounting for two-thirds [6] Company Strategy and Development Direction - The company aims to leverage federal lands for critical energy infrastructure projects, enhancing its project offerings [10] - The focus remains on diversifying energy solutions to meet the increasing demand for distributed and resilient energy systems [5][11] - The company is optimistic about capturing more infrastructure and resiliency projects as government priorities evolve [19] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding the federal contracts, noting that recent cancellations have been rescoped and paused contracts have resumed [7][9] - The company anticipates continued growth in project revenue, with expectations for Q2 revenue to be in the range of $400,000,000 to $425,000,000 [18] - Management highlighted the importance of energy efficiency projects being budget-neutral, which aligns with government interests [24] Other Important Information - The company has a solid cash position of approximately $72,000,000 and total corporate debt of $270,000,000 [17] - The company is actively managing its supply chain to mitigate potential impacts from tariffs and inflation [12][41] Q&A Session Summary Question: Update on federal business visibility and contract situations - Management noted that a canceled contract has been rescoped and paused contracts have resumed, leading to a positive outlook for federal contracts [22][23] Question: Margins for Q2 and the rest of the year - Management expects gross margins for the full year to be in the range of 15.5% to 16%, despite Q1 being slightly lower due to a mix of European EPC contracts [26] Question: Impact of blackouts in Southern Europe on project opportunities - Management indicated that increasing reliance on renewable energy without adequate storage could lead to more outages, highlighting the need for distributed generation solutions [28][30] Question: Economics of projects sensitive to the Inflation Reduction Act - Management has safe harbored the ITC for many projects, minimizing short-term impacts from potential changes in the IRA [32][33] Question: Effects of reduced federal workforce on project timelines - Management has not yet seen negative impacts but acknowledged potential delays in award conversions due to administrative challenges [38][39] Question: Structure of contracts regarding tariffs - Management confirmed that new contracts include protective language against tariffs, allowing for pass-through adjustments to customers [48][50] Question: Observations on private versus public market valuations - Management noted robust private valuations for projects, despite public market fluctuations, indicating strong fundamentals in their offerings [45][46]